Insider trades
Jeffrey Robert Ajer, Director of Nektar Therapeutics NKTR, has filed 0 purchases and 6 sales on the open market. The latest trade was on 09/23.
Jeffrey Robert Ajer
Director
- Company
- Nektar Therapeutics NKTR
- First filing
- 23/01/27
- Trades
- 28 trades
- Buys / sales
- 0 / 6
- 12-month net buying
- No record
- Last trade
- 09/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 24/05/02 | 24/05/06 | 5,000 sh | $82.91 | $414,550 | −7.0% | |
| Open-market sale10b5-1 plan | 24/03/05 | 24/03/07 | 4,000 sh | $87.07 | $348,280 | −4.1% | |
| Open-market sale | 23/09/18 | 23/09/20 | 4,359 sh | $0.69 | $3,007.71 | −11.3% | |
| Open-market sale10b5-1 plan | 23/08/16 | 23/08/17 | 5,000 sh | $90.00 | $450,000 | −7.6% | |
BMRN | Open-market sale | 23/01/25 | 23/01/27 | 49,000 sh2 trades | $115.69avg. | $5,668,937.5 | −54.4% |
